Coexpression of Vimentin and Cytokeratins in Human Melanoma Cell Lines
- Autores: Bogush T.A.1, Kaliuzhny S.A.1, Basharina A.A.1, Bogush E.A.1, Kirsanov V.Y.2, Kosorukov V.S.1, Burova O.S.1, Davydov M.M.2, Baryshnikova M.A.1
-
Afiliações:
- Blokhin Russian Cancer Research Center, Ministry of Health of the Russian Federation
- Sechenov First Moscow State Medical University
- Edição: Volume 74, Nº 6 (2019)
- Páginas: 296-299
- Seção: Article
- URL: https://bakhtiniada.ru/0027-1314/article/view/164045
- DOI: https://doi.org/10.3103/S0027131419060075
- ID: 164045
Citar
Resumo
Abstract—Molecular heterogeneity in seven human metastatic melanoma cells lines is revealed using a double immunofluorescent assay by flow cytometry. It is evaluated that quite a small population of cells (up to 10%) expressed only vimentin, the main marker of melanoma. Only epithelial cytokeratins expression is revealed in a significantly greater number of cells (from 25 to 50%). The dominant molecular phenotype (50–80% cells expressed both markers), the coexpression of vimentin and cytokeratins, is identified for the first time. The authors assume that the latter phenotype of melanoma cells may be a molecular marker of the tumor’s aggressiveness and metastatic potential.
Palavras-chave
Sobre autores
T. Bogush
Blokhin Russian Cancer Research Center, Ministry of Health of the Russian Federation
Autor responsável pela correspondência
Email: tatbogush@mail.ru
Rússia, Moscow
S. Kaliuzhny
Blokhin Russian Cancer Research Center, Ministry of Health of the Russian Federation
Email: tatbogush@mail.ru
Rússia, Moscow
A. Basharina
Blokhin Russian Cancer Research Center, Ministry of Health of the Russian Federation
Email: tatbogush@mail.ru
Rússia, Moscow
E. Bogush
Blokhin Russian Cancer Research Center, Ministry of Health of the Russian Federation
Email: tatbogush@mail.ru
Rússia, Moscow
V. Kirsanov
Sechenov First Moscow State Medical University
Email: tatbogush@mail.ru
Rússia, Moscow
V. Kosorukov
Blokhin Russian Cancer Research Center, Ministry of Health of the Russian Federation
Email: tatbogush@mail.ru
Rússia, Moscow
O. Burova
Blokhin Russian Cancer Research Center, Ministry of Health of the Russian Federation
Email: tatbogush@mail.ru
Rússia, Moscow
M. Davydov
Sechenov First Moscow State Medical University
Email: tatbogush@mail.ru
Rússia, Moscow
M. Baryshnikova
Blokhin Russian Cancer Research Center, Ministry of Health of the Russian Federation
Email: tatbogush@mail.ru
Rússia, Moscow
Arquivos suplementares
